LAVAL, Quebec, April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square") today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer,
J. Michael Pearson
and Pershing Square Chief Executive Officer,
William A. Ackman
, outlining Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN). The webcast and presentations can be accessed by visiting www.vpsevent.com/webcast.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
About Pershing Square
Pershing Square Capital Management, L.P. is a SEC-registered investment advisor based in New York City.
|
Contact Information:
|
|
Valeant Pharmaceuticals:
|
|
Investors:
|
Media:
|
|
Laurie W. Little
|
Renee E. Soto/Meghan Gavigan
|
|
Valeant Pharmaceuticals International, Inc.
|
Sard Verbinnen & Co.
|
|
949-461-6002
|
212-687-8080
|
|
[email protected]
|
[email protected] / [email protected]
|
|
|
|
Pershing Square:
|
|
|
Carolyn Sargent
|
|
|
Rubenstein Associates
|
|
|
212-843-8030
|
|
|
[email protected]
|
|
|
|
|
|
SOURCE Valeant Pharmaceuticals International, Inc.
